Company Overview
Snapshot
Founded in June 2018 by Shachar Paz, Michal Marks, and Assaf Deutsch, NeuroTrigger operates with 1–10 employees. The company has secured $4.12 million in total capital across five funding rounds. In October 2023, NeuroTrigger received FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB).
Business overview
NeuroTrigger is developing a next-generation wearable muscle re-education system designed to improve or facilitate muscle performance, maintain or increase range of motion, and prevent disuse atrophy. Its core technology consists of a lightweight, rechargeable stimulator and a pre-gelled Y-shaped electrode that delivers electrical pulses to re-educate muscles anywhere in the body, including facial musculature. The system is complemented by a mobile application that communicates via Bluetooth, allowing users, caregivers, or technicians to monitor stimulator status and adjust parameters. NeuroTrigger operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices, and serves both B2B and B2C markets, targeting healthcare providers and patients.
Strategic signal
In October 2023, NeuroTrigger received FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB). This regulatory approval is a significant validation of the company's technology, signaling its readiness for broader market adoption and enhancing its credibility within the medical device industry. For investors, this milestone indicates reduced market entry risk and potential for accelerated commercialization.
Log in to access full profile ›Company Intelligence Q&A
- What is NeuroTrigger's primary product?
- NeuroTrigger develops a wearable muscle re-education system composed of a rechargeable stimulator and a pre-gelled Y-shaped electrode, designed to deliver electrical pulses for muscle re-education and performance improvement.
- When was NeuroTrigger founded and by whom?
- NeuroTrigger was founded in June 2018 by Shachar Paz, Michal Marks, and Assaf Deutsch.
- Has NeuroTrigger received any regulatory approvals?
- Yes, in October 2023, NeuroTrigger received FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB).
- What was a notable early recognition for NeuroTrigger?
- In September 2019, NeuroTrigger was named the winner of the Merage 45+ 2019 Startup Competition.
- Which investor participated in a funding round for NeuroTrigger?
- In July 2023, Merage Institute participated as a lead investor in a Seed funding round for NeuroTrigger.